419 related articles for article (PubMed ID: 16099624)
21. Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis.
Lee H; Song JH; Kim SW; Oh WS; Jung SI; Kiem S; Peck KR; Lee NY
Int J Antimicrob Agents; 2004 Mar; 23(3):307-10. PubMed ID: 15164975
[TBL] [Abstract][Full Text] [Related]
22. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
[TBL] [Abstract][Full Text] [Related]
23. Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis.
Domenech A; Cabellos C; Ribes S; Tubau F; Viladrich PF; Liñares J; Gudiol F
Microb Drug Resist; 2003; 9 Suppl 1():S53-9. PubMed ID: 14633368
[TBL] [Abstract][Full Text] [Related]
24. [Antibiotic resistance in Streptococcus pneumoniae strains isolated from sterile body sites].
Oznur AK; Ozer S; Benzonana NA
Mikrobiyol Bul; 2006 Jul; 40(3):179-84. PubMed ID: 17001846
[TBL] [Abstract][Full Text] [Related]
25. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
28. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
[TBL] [Abstract][Full Text] [Related]
29. [Current treatment of pneumococcal meningitis].
Fernández-Viladrich P; Gudiol F
Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):591-3. PubMed ID: 1822147
[No Abstract] [Full Text] [Related]
30. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.
Friedland IR; Paris M; Shelton S; McCracken GH
J Antimicrob Chemother; 1994 Aug; 34(2):231-7. PubMed ID: 7814283
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
[TBL] [Abstract][Full Text] [Related]
33. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.
Klugman KP; Friedland IR; Bradley JS
Antimicrob Agents Chemother; 1995 Sep; 39(9):1988-92. PubMed ID: 8540704
[TBL] [Abstract][Full Text] [Related]
34. Therapy for children with invasive pneumococcal infections. American Academy of Pediatrics Committee on Infectious Diseases.
Pediatrics; 1997 Feb; 99(2):289-99. PubMed ID: 9024464
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
[TBL] [Abstract][Full Text] [Related]
36. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
[TBL] [Abstract][Full Text] [Related]
37. Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis.
Böttcher T; Gerber J; Wellmer A; Smirnov AV; Fakhrjanali F; Mix E; Pilz J; Zettl UK; Nau R
J Infect Dis; 2000 Jun; 181(6):2095-8. PubMed ID: 10837202
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis.
Force E; Taberner F; Cabellos C; Ribes S; Doménech A; Tubau F; Viladrich PF; Gudiol F
Eur J Clin Microbiol Infect Dis; 2009 Jul; 28(7):807-11. PubMed ID: 19221815
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Jan; 45(1):63-8. PubMed ID: 10629014
[TBL] [Abstract][Full Text] [Related]
40. Mortality indicators in pneumococcal meningitis: therapeutic implications.
Erdem H; Elaldi N; Öztoprak N; Sengoz G; Ak O; Kaya S; Inan A; Nayman-Alpat S; Ulu-Kilic A; Pekok AU; Gunduz A; Gozel MG; Pehlivanoglu F; Yasar K; Yılmaz H; Hatipoglu M; Cicek-Senturk G; Akcam FZ; Inkaya AC; Kazak E; Sagmak-Tartar A; Tekin R; Ozturk-Engin D; Ersoy Y; Sipahi OR; Guven T; Tuncer-Ertem G; Alabay S; Akbulut A; Balkan II; Oncul O; Cetin B; Dayan S; Ersoz G; Karakas A; Ozgunes N; Sener A; Yesilkaya A; Erturk A; Gundes S; Karabay O; Sirmatel F; Tosun S; Turhan V; Yalci A; Akkoyunlu Y; Aydın E; Diktas H; Kose S; Ulcay A; Seyman D; Savasci U; Leblebicioglu H; Vahaboglu H
Int J Infect Dis; 2014 Feb; 19():13-9. PubMed ID: 24211227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
